Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06734117 · ClinicalTrials.gov registry record
A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome
A clinical trial, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- 5,429
- Enrollment target
NCT06734117: Completed study, sponsored by Hoffmann-La Roche.
NCT06734117 is a clinical trial that has completed, run by Hoffmann-La Roche. The registered enrollment target is 5,429 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06734117 has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- 5,429 participants
- Enrollment target
Study Summary
This prospective, non-interventional, single arm, longitudinal cohort multicenter study will recruit approximately 5600 consecutive all-comers, consisting of patients with signs and symptoms of acute coronary syndromes (ACS) who present in the emergency department (ED). The main objective of the study is to determine the clinical performance of Elecsys Troponin T hs Gen 6 versus the centrally adjudicated clinical diagnosis at various time points after ED presentation using the previously determined clinical cut-off of a universal 99th percentile upper reference limit.
Primary Outcome
The sensitivity of a diagnostic test is the percentage of true positive (TP) tests out of all patients with a condition. It is calculated as follows: (TP)/(TP + false negatives (FN))\*100%.
Interventions
- PROCEDURE Blood sample collection
- DIAGNOSTIC_TEST Elecsys® Troponin T hs Gen 6
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,429 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2024-12-26 |
What the finished NCT06734117 record still lists
NCT06734117 is an observational study that tracks outcomes without assigning an intervention. Its 5,429 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 2 interventions - of which Blood sample collection is the first listed.
NCT06734117 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06734117 about?
NCT06734117 is a clinical study titled "A Study of Elecsys® Troponin T hs Gen 6 in Participants With Symptoms of Acute Coronary Syndrome". This prospective, non-interventional, single arm, longitudinal cohort multicenter study will recruit approximately 5600 consecutive all-comers, consisting of patients with signs and symptoms of acute coronary syndromes (ACS) who present in the emergency department (ED). The main objective of the stu...
What is the current status of trial NCT06734117?
This trial is currently completed. The enrollment target is 5,429 participants. The study started on 2021-11-15. Estimated completion is 2024-12-26.
What interventions are being tested in trial NCT06734117?
The interventions under investigation include: Blood sample collection (PROCEDURE), Elecsys® Troponin T hs Gen 6 (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06734117?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05722769 · 5,408 participants · NA
CSTOP Now! Child Sex Trafficking Stops With You
- NCT04295486 · 5,478 participants · Phase 2
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
- NCT05952557 · 5,500 participants · Phase 3
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
- NCT06084234 · 5,500 participants · Phase 4
National Liver Cancer Screening Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI